Holen Sie sich die Stockscreener-App
0.4018
5.15%
-0.0218
Vorhandelsmarkt:
.40
-0.0018
-0.45%
Schlusskurs vom Vortag:
$0.4236
Offen:
$0.41
24-Stunden-Volumen:
148.33K
Relative Volume:
0.17
Marktkapitalisierung:
$3.74M
Einnahmen:
$2.18M
Nettoeinkommen (Verlust:
$-34.17M
KGV:
-0.0132
EPS:
-30.4847
Netto-Cashflow:
$-12.41M
1W Leistung:
+5.46%
1M Leistung:
+7.63%
6M Leistung:
-85.39%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.3815
$0.4299
1-Wochen-Bereich:
$0.367
$0.4979
52-Wochen-Spanne:
$0.29
$6.09
Envue Medical Inc Stock (FEED) Company Profile
Firmenname
Envue Medical Inc
Sektor
Branche
Telefon
(914) 233-3004
Adresse
969 PRUITT AVE,, TYLER
Compare FEED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEED
Envue Medical Inc
|
0.4018 | 3.94M | 2.18M | -34.17M | -12.41M | -30.48 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envue Medical Inc Aktie (FEED) Neueste Nachrichten
symbol__ Stock Quote Price and Forecast - CNN
FEED Looks 90.5% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million - marketscreener.com
Peak Medical's annual UroShield commitment goes from 650 to 35,000 units by 2029 - Stock Titan
ENvue Medical Q2 Net Loss Narrows to $3.8M on Lower Expenses - Minichart
ENvue Medical, Inc. 2026: Revenue $239K, EPS ($1.98) — 10-Q Summary - TradingView
ENvue Medical (FEED) raises going-concern doubt, adds equity facility - Stock Titan
ENvue Medical (FEED) Surges 14.7% as Shares Approach Key ResistanceAndrews Pitchfork - Vinanet
ENvue Medical Delays Quarterly Filing Briefly - tipranks.com
ENvue Medical Shareholders Approve Reverse Stock Split Plan - tipranks.com
ENvue Medical, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Envue MedicalStockholders Approve Reverse Stock Split At Ratio Between 1-For-2 And 1-For-50 - TradingView
ENvue Medical (FEED) Slides 6.5% to $0.38 as Support Level Comes into FocusOBV Divergence - Vinanet
ENvue Medical (FEED) Drops 12% — Critical Support Test Looms at $0.34High Low Breadth - Vinanet
ENvue Medical secures USD 50M equity financing - Medical Buyer
FEED Looks 91.4% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
This Is An (EARLY) Once-In-A-Lifetime Opportunity Gage Workman (xJ49zNTJsu) - Mshale
Form 8K ENvue Medical Inc For: 12 August By Investing.com - Investing.com Australia
ENvue Medical secures $50M equity financing facility By Investing.com - Investing.com Canada
ENvue Medical Establishes Major Equity Financing Facility - TipRanks
ENvue Medical secures $50M equity financing facility - Investing.com
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions - The Manila Times
ENvue Medical Secures Equity Financing Facility of Up to - GlobeNewswire
ENvue Medical Secures $50 Million Equity Facility; Expands Series H Investment Rights to $59 Million - TradingView
ENVUE Medical (FEED) adds $50M equity facility and boosts $59M Series H rights - stocktitan.net
Envue Medical signs committed equity facility for up to $50 million common stock sales - Bitget
ENvue Medical Ord Shs (FEED) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENvue Medical, Inc. announced that it expects to receive $50 million in funding - marketscreener.com
ENvue Medical (FEED) seeks up to $50M via shelf for stock, warrants, units - Stock Titan
Enterprise value to EBITDA forward of ENvue Medical, Inc. – NASDAQ:FEED - TradingView
FEED Q1 2026 Earnings: Reported Loss of $6.88 Per Share Amid Minimal DisclosureRevenue Report - Vinanet
ENvue Medical completes US manufacturing transition By Investing.com - Investing.com South Africa
ENvue Medical Completes Transition of NanoVibronix Manufacturing to US, Consolidates R&D in Tel Aviv - marketscreener.com
ENvue Medical completes US manufacturing transition - Investing.com
ENvue Medical completes manufacturing shift to U.S. By Investing.com - Investing.com South Africa
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities - Yahoo Finance
ENvue Medical (FEED) Climbs 8.8% to $0.34, Approaching Key Resistance ZoneNAAIM Exposure - Vinanet
Meet the robotics companies rethinking clinical care - Modern Healthcare
FEED Q1 2026 Earnings: Significant Loss Reported Amid Limited Financial DisclosureRevenue Guidance Update - Vinanet
ENvue Medical develops robotic feeding tube placement system - The Robot Report
FEED|ENvue Medical Ord Shs|Price:0.400|Chg%:+0.005 - TradingKey
ENvue Medical, Inc. Revenue Breakdown – NASDAQ:FEED - TradingView
Form DEF 14A ENvue Medical Inc For: 24 July By Investing.com - Investing.com South Africa
ENvue Medical deploys additional platform at Texas medical center - Investing.com
ENvue Medical deploys additional platform at Texas medical center By Investing.com - Investing.com Canada
ENvue Medical Expands ENvue Navigation Platform Deployment at Major Dallas-Fort Worth Academic Medical Center - Quiver Quantitative
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center - GlobeNewswire
Dallas-Fort Worth medical center adds bedside feeding-tube navigation - Stock Titan
ENvue Medical Inc. (FEED) Shows Modest Uptick Amid Key Technical LevelsNHNL Divergence - dars.gov.et
ENvue Medical demonstrates robotic feeding tube prototype By Investing.com - Investing.com Nigeria
Finanzdaten der Envue Medical Inc-Aktie (FEED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):